Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
L’Oreal prevails in anti-aging treatment clash
article
Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.   12 January 2023
Drugs to Watch report: 15 blockbusters for 2023
Big Pharma
Clarivate study highlights treatments with blockbuster potential | IV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer make the list | Nine blockbusters from China also predicted.   12 January 2023
Gilead avoids $1.2bn patent clash at SCOTUS
Americas
Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.   10 January 2023
article
German IP specialist gears up for UPC with experienced partner | Patent litigator previously led practice at IP boutique Meissner Bolte.   10 January 2023
Europe
‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies.   5 January 2023
Americas
Distributors and pharmacies face millions in damages and costs after selling international versions of Abbott products in the US | Fraud upon the court discovered after a court-authorised search of defendant’s premises seized an email server.   4 January 2023
Big Pharma
California-based company alleges competitor stole secrets following a collaboration bid | Complaint says Chinese competitor founded a sister company to develop rival treatment for metabolic disorders.   3 January 2023
Americas
Addition is a former chair of a patent practice group | New partner has expertise in complex disputes over medical devices | Barnes & Thornburg | Patterson Thuente Pedersen.   22 December 2022
Big Pharma
Counterfeit medicine and drugs cause more than one million deaths a year | Trio of bodies will work jointly together | National Intellectual Property Rights Coordination Center | Homeland Security Investigations.   22 December 2022
Americas
Delisting affects a blockbuster narcolepsy drug | Orange book has specific listing criteria | Avadel.   22 December 2022